Prevalence of type 1 Brugada ECG pattern after administration of Class 1C drugs in patients with type 1 myotonic dystrophy: Myotonic dystrophy as a part of the Brugada syndrome

被引:14
作者
Maury, Philippe [1 ]
Audoubert, Mathieu [1 ]
Cintas, Pascal [2 ]
Rollin, Anne [1 ]
Duparc, Alexandre [1 ]
Mondoly, Pierre [1 ]
Chiriac, Ana-Maria [3 ]
Acket, Blandine [2 ]
Zhao, Xinran [3 ]
Pasquie, Jean Luc [3 ]
Cardin, Christelle [1 ]
Delay, Marc [1 ]
Sadron, Marie [1 ]
Carrie, Didier [1 ]
Galinier, Michel [1 ]
Davy, Jean-Marc [3 ]
Arne-Bes, Marie-Christine [2 ]
Raczka, Franck [3 ]
机构
[1] Univ Hosp Rangueil Toulouse, Dept Cardiol, Toulouse, France
[2] Univ Hosp Rangueil Toulouse, Dept Neurol, Toulouse, France
[3] Univ Hosp Arnaud de Villeneuve, Dept Cardiol, Montpellier, France
关键词
Brugada syndrome; Myotonic dystrophy; Sudden death; ST elevation; VENTRICULAR-TACHYCARDIA; SUDDEN-DEATH; ARRHYTHMIAS; MORTALITY; DISEASE;
D O I
10.1016/j.hrthm.2014.07.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Both type 1 myotonic dystrophy (MD1) and Brugada syndrome (BrS) may be complicated by conduction disturbances and sudden death. Spontaneous BrS has been observed in MD1 patients, but the prevalence of drug-induced BrS in MD1 is unknown. OBJECTIVE The purpose of this study was to prospectively assess the prevalence of type 1 ST elevation as elicited during pharmacologic challenge with Class 1C drugs in a subgroup of MD1 patients and to further establish correlations with ECG and electrophysioLogic variables and prognosis. METHODS From a group of unselected 270 MD1 patients, ajmaline or flecainide drug challenge was performed in a subgroup of 44 patients (27 men, median age 43 years) with minor depolarization/repoLarization abnormalities suggestive of possible BrS. The presence of type 1 ST elevation after drug challenge was correlated to clinical, ECG, and electrophysiologic variables. RESULTS Eight of 44 patients (18 /0) presented with BrS after drug challenge. BrS was seen more often in men (26% vs 6%, P =.09) and was related to younger age (35 vs 48 years, P =.07). BrS was not correlated to symptoms, baseline ECG, HV interval, results of signal-averaged ECG, or abnormalities on ambulatory recordings. MD1 patients with BrS had longer corrected QT intervals, greater increase in PR interval after drug challenge, and higher rate of inducible ventricular arrhythmias (62% vs 21%, P =.03). Twelve patients were implanted with a pacemaker and 5 with an implantable cardioverter-defibrillator. Significant bradycardia did not occur in any patients, and malignant ventricular arrhythmia never occurred during median 7-year follow-up (except 1 hypokalemiarelated ventricular fibrillation). CONCLUSION BrS is elicited by a Class 1 drug in 18% of MD1 patients presenting with minor depolarization/repolarization abnormalities at baseline, but the finding seems to be devoid of a prognostic role.
引用
收藏
页码:1721 / 1727
页数:7
相关论文
共 32 条
  • [1] Antzelevitch C, 1999, CLIN APPROACHES TACH, V10, P73
  • [2] Pacemaker and Implantable Cardioverter-Defibrillator Use in a US Myotonic Dystrophy Type 1 Population
    Bhakta, Deepak
    Shen, Changyu
    Kron, Jack
    Epstein, Andrew E.
    Pascuzzi, Robert M.
    Groh, William J.
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2011, 22 (12) : 1369 - 1375
  • [3] DYSTROPHICA MYOTONIA - CORRELATIVE ELECTROCARDIOGRAPHIC, ELECTROPHYSIOLOGIC, AND CONDUCTION SYSTEM STUDY
    BHARATI, S
    BUMP, FT
    BAUERNFEIND, R
    LEV, M
    [J]. CHEST, 1984, 86 (03) : 444 - 450
  • [4] MOLECULAR-BASIS OF MYOTONIC-DYSTROPHY - EXPANSION OF A TRINUCLEOTIDE (CTG) REPEAT AT THE 3' END OF A TRANSCRIPT ENCODING A PROTEIN-KINASE FAMILY MEMBER
    BROOK, JD
    MCCURRACH, ME
    HARLEY, HG
    BUCKLER, AJ
    CHURCH, D
    ABURATANI, H
    HUNTER, K
    STANTON, VP
    THIRION, JP
    HUDSON, T
    SOHN, R
    ZEMELMAN, B
    SNELL, RG
    RUNDLE, SA
    CROW, S
    DAVIES, J
    SHELBOURNE, P
    BUXTON, J
    JONES, C
    JUVONEN, V
    JOHNSON, K
    HARPER, PS
    SHAW, DJ
    HOUSMAN, DE
    [J]. CELL, 1992, 68 (04) : 799 - 808
  • [5] RNA pathogenesis of the myotonic dystrophies
    Day, JW
    Ranum, LPW
    [J]. NEUROMUSCULAR DISORDERS, 2005, 15 (01) : 5 - 16
  • [6] Risk of Arrhythmias in MYotonic Dystrophy: trial design of the RAMYD study
    Dello Russo, Antonio
    Mangiola, Fortunato
    Della Bella, Paolo
    Nigro, Giovanni
    Melacini, Paola
    Bongiorni, Maria Grazia
    Tondo, Claudio
    Calo, Leonardo
    Messano, Loredana
    Pace, Manuela
    Pelargonio, Gemma
    Casella, Michela
    Sanna, Tommaso
    Silvestri, Gabriella
    Modoni, Anna
    Zachara, Elisabetta
    Moltrasio, Massimo
    Morandi, Lucia
    Nigro, Gerardo
    Politano, Luisa
    Palladino, Alberto
    Bellocci, Fulvio
    [J]. JOURNAL OF CARDIOVASCULAR MEDICINE, 2009, 10 (01) : 51 - 58
  • [7] Fazio B, 1988, Minerva Med, V79, P137
  • [8] CHARACTERISTICS OF NA+ CHANNELS AND CL- CONDUCTANCE IN RESEALED MUSCLE-FIBER SEGMENTS FROM PATIENTS WITH MYOTONIC-DYSTROPHY
    FRANKE, C
    HATT, H
    IAIZZO, PA
    LEHMANNHORN, F
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 1990, 425 : 391 - 405
  • [9] GRIGG LE, 1985, J AM COLL CARDIOL, V6, P254, DOI 10.1016/S0735-1097(85)80286-2
  • [10] Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1
    Groh, William J.
    Groh, Miriam R.
    Saha, Chandan
    Kincaid, John C.
    Simmons, Zachary
    Ciafaloni, Emma
    Pourmand, Rahman
    Otten, Richard F.
    Bhakta, Deepak
    Nair, Girish V.
    Marashdeh, Mohammad M.
    Zipes, Douglas P.
    Pascuzzi, Robert M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (25) : 2688 - 2697